These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20194578)

  • 1. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
    Deloire M; Ruet A; Hamel D; Bonnet M; Brochet B
    Mult Scler; 2010 May; 16(5):581-7. PubMed ID: 20194578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
    Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of cognitive impairment in the expanded disability status scale of 215 patients with multiple sclerosis.
    Brissart H; Sauvée M; Latarche C; Dillier C; Debouverie M
    Eur Neurol; 2010; 64(6):345-50. PubMed ID: 21071951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
    Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].
    Kotterba S; Eren E; Fangerau T; Malin JP; Sindern E
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):590-4. PubMed ID: 14608510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.